Lasa Supergenerics Limited has informed the Exchange about General Updates
LASA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lasa Supergenerics has informed exchanges that operations at its manufacturing facility, which suffered a fire incident on 18th May 2025, cannot be resumed despite sustained efforts. The inability to restart is due to pending statutory clearances and certain operational constraints. The company is now exploring alternative options such as entering into contract manufacturing arrangements or leasing the facility, subject to regulatory approvals. This is a follow-up to a previous disclosure dated 24th June 2025. The facility is located at MIDC Lote Parshuram, Ratnagiri.
Negative for shareholders — permanent loss of in-house manufacturing capacity at the affected plant raises concerns about revenue continuity and may pressure margins if contract manufacturing costs are higher. Uncertainty around the alternative arrangement timeline could weigh on the stock in the near term.